ALOPEXY

This brand name is authorized in Austria, Spain, France, Poland, Romania, Tunisia, Turkey

Active ingredients

The drug ALOPEXY contains one active pharmaceutical ingredient (API):

1 Minoxidil UNII 5965120SH1 - MINOXIDIL

Topical administration of minoxidil stimulates hair growth in men and women with androgenic alopecia. The mechanism of stimulating hair growth from minoxidil is not fully understood, but some actions of minoxidil include increasing hair diameter, stimulating new growth and prolonging the developmental phase, and stimulating hair follicle transition from resting phase (telogen) in the growth phase (regenerative). Read about Minoxidil

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D11AX01	Minoxidil	D Dermatologicals → D11 Other dermatological preparations → D11A Other dermatological preparations → D11AX Other dermatologicals
Discover more medicines within D11AX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 72923
Country: FR	Base de données publique des médicaments	Identifier(s): 62725176, 69301899
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100241373
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W69417001, W69417002, W69419001, W69419002
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 9323121, 9323122
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8681349103021